Health
Pfizer Drug Trial Fails
Pfizer announced that its experimental lung cancer drug failed in a clinical trial, potentially impacting treatment options for one of the most common forms of the disease.
Coverage timeline — 1 article
STAT News
Pfizer said an experimental drug it hoped could replace a widely used chemotherapy in one of the most common forms of lung cancer fell short in a clinical trial.
2026-06-22 21:36 UTC